Ainos, Inc.
AIMD
Rank in Stocks
#30765
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Share Price
$0.6
Last synced: 2026-11-09
Market Cap
$4.43M
Change (1 day)
-14.04%
Change (1 year)
-80.77%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Ainos, Inc. (AIMD)
Category
Healthcare
Operating Margin for Ainos, Inc. (AIMD)
Operating Margin as of November 2026 TTM: -101,210.17%
According to Ainos, Inc.'s latest financial reports, its current operating margin (TTM) is -101,210.17%. At the end of 2025 the company had an operating margin of -11,268.32%.
Operating Margin history for Ainos, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -101,210.17% | 798.18% |
| 2025 | -11,268.32% | -83.12% |
| 2024 | -66,772.17% | 517.40% |
| 2023 | -10,814.99% | 2,623.56% |
| 2022 | -397.09% | -38.95% |
| 2021 | -650.47% | -92.52% |
| 2020 | -8,696.70% | -35.45% |
| 2019 | -13,472.11% | 684.54% |
| 2018 | -1,717.20% | 643.22% |
| 2017 | -231.05% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | -26,320.05% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | -100.00% |
| 2012 | -104,643.02% | 5,232.70% |
| 2011 | -1,962.29% | -90.55% |
| 2010 | -20,763.38% | 561.14% |
| 2009 | -3,140.52% | 87.80% |
| 2008 | -1,672.27% | -51.55% |
| 2007 | -3,451.34% | 71.89% |
| 2006 | -2,007.91% | 465.96% |
| 2005 | -354.78% | -63.22% |
| 2004 | -964.69% | 103.32% |
| 2003 | -474.46% | -37.66% |
| 2002 | -761.04% | 1,277.20% |
| 2001 | -55.26% | -99.10% |
| 2000 | -6,162.25% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.00% |
US
|
|
| -149.01% | -100.00% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Ainos, Inc.'s operating margin
What is Ainos, Inc.'s operating margin?
Ainos, Inc.'s operating margin is -101,210.17%, as of Nov 2026.
What was Ainos, Inc.'s operating margin in 2025?
In 2025, Ainos, Inc.'s operating margin was -11,268.32%, compared with -66,772.17% in 2024.
How has Ainos, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Ainos, Inc.'s operating margin was highest in 2022 (-397.09%) and lowest in 2024 (-66,772.17%).
How does Ainos, Inc.'s operating margin compare with similar companies?
Ainos, Inc.'s operating margin (-101,210.17%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.